Investigator-Led Research That Transforms Lives

Leading the charge in inclusive, equity-centered research that addresses healthcare's most pressing needs

At Rubix LS, our research leverages over 17 million patient data records that go beyond traditional studies. We initiate and lead projects to transform healthcare for underserved communities, conducting investigator-led studies that explore critical areas where healthcare gaps persist. Our research combines scientific precision with a commitment to inclusivity, integrating underserved patient data to develop findings that are representative, reliable, and impactful.

Underserved Patient Data – A Foundation for Insightful Research

Ensuring that research reflects the full spectrum of patient experiences.

Rubix LS places underserved patient data at the center of our research framework. By collecting and analyzing data from historically underrepresented populations, we build a comprehensive picture of healthcare needs and opportunities. This approach improves study quality and contributes to health equity by recognizing and addressing the unique challenges these populations face.

OUr targeted Research Focus Areas

Precision medicine & early stage discovery

We focus on advancing precision medicine by developing innovative therapies tailored to the needs of diverse patient groups. Our research is designed to break new ground in early-stage discovery, providing insights that guide the development of effective, targeted treatments.

Chronic disease and health disparities

Chronic diseases disproportionately affect underserved communities. Our research aims to address these disparities by identifying specific risk factors and treatment pathways that can improve patient outcomes in conditions such as cardiovascular disease, diabetes, and cancer.

Neuro and mental health

Neurodegenerative and mental health disorders present complex challenges requiring innovative solutions. Rubix LS’s research seeks to uncover novel biomarkers and therapeutic pathways for conditions like dementia, Parkinson’s disease, and depression, especially within populations underrepresented in mental health research.

Women's Health, oncology, & Rare Disease

In oncology and rare disease research, data from diverse groups is essential to create therapies that are effective for all. Our work spans from early detection initiatives to advanced treatment development, using underserved patient data to inform every stage.

Innovative Research Methodologies

Data Driven Analytics & AI Integration

Rubix LS employs advanced analytics and AI to uncover hidden patterns in underserved patient data, allowing for more precise and actionable insights. These technologies support rapid data processing and provide a foundation for informed decision-making across all research stages.

Mobile and Decentralized Clinical Sites

To reach underserved communities, we leverage mobile clinical sites that allow us to conduct studies directly within these populations. This decentralized model reduces barriers to participation, increases data diversity, and creates a more inclusive research process.

Real-World Data Collection

We prioritize real-world data (RWD) to enrich our research findings, using this information to create a full spectrum of patient experiences and treatment outcomes. RWD enables us to draw meaningful conclusions on how therapies perform outside of controlled environments, leading to more relevant, applicable insights.

Various Indications

Women's Health

Pediatric Cancers

Pediatric Health

Healthcare, child or holding hands in hospital bed with medicine, medical therapy or IV dr

Various Indications

Oncology

Clinical Trials

Our clinical trials are a core part of our R&D efforts, with a focus on ensuring safety and efficacy for our target populations.

This list of Rubix LS trials will be updated periodically.

Rare & Ultra Rare

Rare Disease

Various Indications

Chronic Conditions

Portrait of a happy middle aged woman and active middle aged white couple having fun walk

Longevity

Aging in Place

Collaborations & Partnerships

We are building bridges with organizations dedicated to equitable healthcare.

Rubix LS collaborates with partners who share our commitment to inclusive, equity-centered research. By partnering with academic institutions, pharmaceutical companies, and community organizations, we expand our reach, amplify our impact, and work together to make high-quality healthcare accessible to all.

OUR JOURNEY

2016

RUBIX LS IS FOUNDED

Rubix LS was founded with the mission of conducting research that makes a difference in the lives of patients. From the beginning, we have been committed to putting patients first and developing treatments that meet their needs.

2017

FIRST CLINICAL TRIAL BEGINS

Rubix LS conducts its first clinical trial, testing a new therapy for a rare form of osteonecrotic cancer. The trial results are promising, and the therapy is undergoing continuous studies for approval for use in patients.

Rubix LS

Headquarters:

60 Island St, Suite 236

Lawrence, MA 01840

Tel: 978-552-3183

Email: info@rubixls.com